Roundtable Discussion – Challenges & Solutions to Personalized Cancer Immunotherapy From Design to Manufacture
- Overcoming the challenges of small-scale GMP manufacturing capability on CMO/CDMO services for the personalized cancer vaccine, contributing to the increase in cost of manufacturing
- Harmonizing the regulatory guidelines around the personalized cancer vaccine
- Discussing the potential marketability of the personalized cancer vaccines in the future